J. Lee

Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants

Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications

Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1

PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers

Hallmarks of Cancer: The Next Generation

Synthetic lethality: a framework for the development of wiser cancer therapeutics

Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution

Mixed Adenocarcinomas of the Lung: Place in New Proposals in Classification, Mandatory for Target Therapy

The tumor suppressor kinase LKB1: lessons from mouse models

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

The Concept of Synthetic Lethality in the Context of Anticancer Therapy

AMPK: guardian of metabolism and mitochondrial homeostasis

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

The biology and management of non-small cell lung cancer

Choosing anticancer drug targets in the postgenomic era

Lung Cancer

Lung Cancer: Epidemiology, Etiology, and Prevention

Control and integration of cell signaling pathways during C. Elegans vulval development

RAS Is Regulated by the let-7 MicroRNA Family

LKB1; linking cell structure and tumor suppression

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer

Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells

The PI3K Pathway in Human Disease

The biology and treatment of EML4-ALK non-small cell lung cancer

lin-35 and lin-53, Two Genes that Antagonize a C. elegans Ras Pathway, Encode Proteins Similar to Rb and Its Binding Protein RbAp48

Pattern formation during C. elegans vulval induction

Artificial intelligence in healthcare

Slaying RAS with a synthetic lethal weapon

Inhibition of class IA PI3K enzymes in non-small cell lung cancer cells uncovers functional compensation among isoforms

Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma

Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers

Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen

Requirement for p53 and p21 to Sustain G ₂ Arrest After DNA Damage

Mixed adenocarcinomas of the lung: place in new proposals in classification, mandatory for target therapy.

Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation

Metabolic reprogramming and cancer progression

Integrating Genetic Approaches into the Discovery of Anticancer Drugs

Signal Transduction through MAP Kinase Cascades

ARK-1 Inhibits EGFR Signaling in C. elegans

Gain-of-Function Mutations in the Caenorhabditis elegans lin-1 ETS Gene Identify a C-Terminal Regulatory Domain Phosphorylated by ERK MAP Kinase

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients

Molecular Genetics of Proto-oncogenes and Candidate Tumor Suppressors in Caenorhabditis elegans